Charles Schwab’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Sell
727,937
-21,024
-3% -$624K ﹤0.01% 1929
2025
Q4
$23.3M Buy
748,961
+153,600
+26% +$4.21M ﹤0.01% 1655
2025
Q3
$12.8M Buy
595,361
+21,340
+4% +$385K ﹤0.01% 1990
2025
Q2
$8.02M Buy
574,021
+8,058
+1% +$109K ﹤0.01% 2119
2025
Q1
$7.63M Sell
565,963
-9,107
-2% -$155K ﹤0.01% 2084
2024
Q4
$11M Buy
575,070
+58,857
+11% +$1.28M ﹤0.01% 1968
2024
Q3
$11.7M Buy
516,213
+32,292
+7% +$528K ﹤0.01% 1952
2024
Q2
$6.3M Buy
483,921
+59,836
+14% +$828K ﹤0.01% 2252
2024
Q1
$7.43M Buy
424,085
+52,774
+14% +$1.02M ﹤0.01% 2136
2023
Q4
$8.09M Buy
371,311
+58,094
+19% +$917K ﹤0.01% 2100
2023
Q3
$4.8M Buy
313,217
+197,430
+171% +$3.77M ﹤0.01% 2280
2023
Q2
$2.75M Buy
115,787
+11,717
+11% +$301K ﹤0.01% 2455
2023
Q1
$2.65M Buy
104,070
+1,830
+2% +$58.7K ﹤0.01% 2449
2022
Q4
$2.99M Buy
102,240
+28,691
+39% +$661K ﹤0.01% 2439
2022
Q3
$1.51M Buy
73,549
+5,303
+8% +$95.3K ﹤0.01% 2661
2022
Q2
$790K Buy
+68,246
New +$917K ﹤0.01% 2885
2019
Q2
Sell
-3,200
Closed -$134K 3267
2019
Q1
$134K Hold
3,200
﹤0.01% 3070
2018
Q4
$146K Hold
3,200
﹤0.01% 3057
2018
Q3
$268K Hold
3,200
﹤0.01% 3027
2018
Q2
$308K Buy
3,200
+873
+38% +$92.3K ﹤0.01% 2953
2018
Q1
$245K Buy
2,327
+907
+64% +$98.5K ﹤0.01% 2941
2017
Q4
$223K Hold
1,420
﹤0.01% 2962
2017
Q3
$195K Hold
1,420
﹤0.01% 3017
2017
Q2
$276K Buy
+1,420
New +$240K ﹤0.01% 2900

Other funds holding VRDN